异位妊娠或输卵管积水行输卵管切除术后卵巢癌风险:OCASE全国人群数据库研究
该全国人群数据库研究比较了因异位妊娠或输卵管积水行输卵管切除术的女性与对照组之间卵巢癌的发病率,发现输卵管切除术后卵巢癌风险并无显著降低,年龄调整后的风险比为0.76(95%CI 0.39-1.47)。亚组分析未发现随访时间与保护效应之间存在显著差异。
要点
- 输卵管切除术后卵巢癌风险未显著降低,年龄调整HR为0.76(95%CI 0.39-1.47)。
- 单侧与双侧输卵管切除术的年龄调整HR分别为0.81和0.43,均无统计学意义。
- 随访至少8年的亚组中卵巢癌发病率差异最大,但P=0.08未达显著。
核心结论
- 因异位妊娠或输卵管积水行输卵管切除术并未显著降低卵巢癌风险。
研究设计与样本
- 全国人群数据库研究,使用荷兰病理数据库纳入1990年1月至2012年12月因异位妊娠或输卵管积水行输卵管切除术的女性,与按手术时年龄和年份匹配的良性皮痣切除对照组比较卵巢癌发病率。
主要发现
- 干预组卵巢癌14例,发病率为5.4(95%CI 3.1-8.9)/10万人年;对照组24例,发病率为7.1(95%CI 4.7-10.5)/10万人年(P=0.34)。
- 输卵管切除术后年龄调整HR为0.76(95%CI 0.39-1.47);单侧为0.81(95%CI 0.41-1.59),双侧为0.43(95%CI 0.06-3.16,基于1例)。
- 随访至少8年的女性中卵巢癌发病率差异最大(P=0.08),但所有滞后时间亚组分析均未显示显著差异。
临床怎么用
- 对于因异位妊娠或输卵管积水行输卵管切除术的年轻女性,不应预期卵巢癌风险在术后短期内显著下降。
- 输卵管切除术对卵巢癌的预防作用可能需要更长随访时间才能显现,临床咨询时应告知现有证据未显示显著保护效应。
局限性
- 研究人群年轻,卵巢癌发病率低,即使随访结束时事件数仍较少。
- 病理登记库为匿名数据,无法调整混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What is the effect of salpingectomy for ectopic pregnancy or hydrosalpinx at a young age on ovarian cancer risk compared to no salpingectomy for any reason? SUMMARY ANSWER: We found no significant reduction in ovarian cancer risk after salpingectomy for ectopic pregnancy or hydrosalpinx. WHAT IS KNOWN ALREADY: Salpingectomy may reduce ovarian cancer incidence, although the lag-time between intervention and therapeutic effect remains to be elucidated. STUDY DESIGN, SIZE, DURATION: This nationwide population-based database study uses the Dutch pathology database to identify all women who underwent salpingectomy for ectopic pregnancy or hydrosalpinx between January 1990 and December 2012 and compared ovarian cancer incidence to a control group of women who had a benign dermal nevus removed, matched for age at the time and year of procedure. PARTICIPANTS/MATERIALS, SETTING, METHODS: After selection and manual control of intervention and control group, ovarian cancer incidence was recorded. Hazard ratios (HRs) with 95% CI for the development of ovarian cancer were calculated with Cox regression analyses, both unadjusted and adjusted for age. Subgroup analyses were performed to investigate lag-time between intervention and protective effect. MAIN RESULTS AND THE ROLE OF CHANCE: In all, 18 961 women were included in the intervention group; 17 106 women had a unilateral salpingectomy and 1855 had a bilateral salpingectomy. The control group consisted of 23 686 women. With 14 ovarian cancer cases in the intervention group, the incidence rate (IR) of ovarian cancer was 5.4 (95% CI 3.1-8.9) per 100 000 person-years. In the control group, there were 24 ovarian cancer cases, resulting in an IR of 7.1 (95% CI 4.7-10.5) per 100 000 person-years (P = 0.34). The age-adjusted HR for ovarian cancer was 0.76 (95% CI 0.39-1.47) after salpingectomy. Unilateral salpingectomy resulted in an age-adjusted HR of 0.81 (95% CI 0.41-1.59) and bilateral salpingectomy resulted in an age-adjusted HR of 0.43 (95% CI 0.06-3.16) based on one case. None of our subgroup analysis for lag-time resulted in a significant difference in ovarian cancer incidence between intervention and control group. The difference in ovarian cancer incidence appeared largest in women with at least 8 years of follow-up (P = 0.08). LIMITATIONS, REASONS FOR CAUTION: Due to the young population, ovarian cancer incidence is low, even at the end of follow-up. Furthermore, due to the anonymous nature of the pathology registry, we were unable to adjust for confounding factors. WIDER IMPLICATIONS OF THE FINDINGS: Although results did not reach statistical significance, they add to the available data on ovarian cancer incidence after salpingectomy. Our subgroup analysis suggests there may be no benefit in the first years following salpingectomy. STUDY FUNDING/COMPETING INTEREST(S): None. TRIAL REGISTRATION NUMBER: N/A.
引用
- van Lieshout LAM, Piek JMJ, Verwijmeren K, et al. Ovarian cancer risk after salpingectomy for ectopic pregnancy or hydrosalpinx: results of the OCASE nationwide population-based database study. Hum Reprod. 2021. PMID: 33156914. doi:10.1093/humrep/deaa264
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。